Reducing Immunogenicity of Pegloticase (RECIPE) with Concomitant Use of Mycophenolate Mofetil in Patients with Refractory Gout—a Phase II Double Blind Randomized Controlled Trial
Click here to view the visual abstract summaryGout Resource Center
Earlier this year, the ACR released a new guideline for the management of gout, leaving some rheumatologists unsure what to recommend to their patients. Clearing up the confusion is one aim of the session, Evidence-Based Guidance for Optimizing Gout Management. Learn what the experts recommend and explore our coverage of additional gout information presented at ACR Convergence 2020, plus our collection of research reviews, case reports and clinical articles on advances in the diagnosis and management of gout.
VIEW
Click here to view the visual abstract summary
Dr. Ethan Craig Picks His Favorite Gout Abstracts from ACR Convergence 2020
Optimize Gout Management with the Latest Evidence-Based Guidance
FAST Results for Febuxostat Safety in Gout Patients
High Opioid Prescription Rates Seen in Emergency Department-Treated Gout
Bringing Consistency to Gout Terms & Concepts
Gout: The State of the Science
The ACR Releases a New Gout Guideline
The Latest Advances in Sjögren’s, Scleroderma, RA, Gout & More
New Study Identifies How Big a Role Diet Plays in Hyperuricemia
- 1
- 2
- 3
- …
- 11
- Next Page »